Navigation Links
New uses for imidazolium salts in medicine and alternative energy
Date:12/2/2008

rn. Biofuels are currently the only sustainable source of liquid fuels available, but the lack of highly efficient methods to convert carbohydrates into chemical compounds for biofuel production has impeded the replacement of petroleum feedstock by biomass.

HMF and its 2,5-disubstituted furan derivatives can replace key petroleum-based building blocks, and there are several known catalysts that are active in the dehydration of sugars to form HMF.

However, most of them also produce side reactions that form undesired byproducts, and rehydrate HMF to form acid. Therefore, the use of these catalysts has often been constrained to simple sugar feedstock such as fructose. They have not been able to efficiently convert glucose, a more abundant and stable sugar source.

With IMSs as the starting point, IBN researchers developed NHC-metal complexes as catalysts to transform sugars into HMF. These offer a great deal of flexibility as the catalytic activity may be modified by changing specific properties of the NHC. The researchers were able to extract HMF easily as the sole product. IBN's new catalyst achieved the highest reported yields of HMF so far, for both fructose and glucose feedstocks.

Dr. Zhang said, "Our HMF yields were as high as 96% for fructose and 81% for glucose. As both the catalyst and the ionic liquid can be recycled, our technology is more environmentally friendly and would potentially lead to cost savings in the biofuel manufacturing process."

IBN Executive Director Professor Jackie Y. Ying added, "We are excited by the tremendous potential of these novel compounds to make an impact on medicine and alternative energy. Our discovery paves the way for more effective treatment of various degenerative diseases, as well as the conversion of biofuels, helping to alleviate some of the pressing concerns facing our global community."


'/>"/>

Contact: Cathy Yarbrough
sciencematter@yahoo.com
858-243-1814
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert

Page: 1 2 3

Related biology technology :

1. Diffusion Pharmaceuticals Announces Issuance of U.S. Patent No. 7351844, Titled Bipolar Trans Carotenoid Salts and Their Uses, for Its Family of First-In-Class Molecules
2. China Medicine Corporation Awarded GSP Certification
3. GeneNews to exhibit ColonSentry(TM) at Family Medicine Forum 2008
4. Sigma-Aldrich Enters Into Research Collaboration Program With D-Finitive Cell Technologies, Inc., to Develop Research Tools for Regenerative Medicine
5. MDV Expands Team Pursuing Advances in Personalized Medicine
6. Singapore Medicine - Singapore Doctors Use Hi-Tech Implant to Add Space to Narrowed Spinal Canals
7. Dr. Gail Naughton Speaks on Histogen's Business Plan and the Rise of Bioaesthetic Medicine during Commercial Translation of Regenerative Medicine
8. Chemical Engineering Conference Highlights Energy, Biomedicine, Pharmaceuticals, Sustainability and Centennial
9. AstraZeneca Nobel Medicine Initiative to Increase Interest in the Nobel Prize in Physiology or Medicine
10. China Medicine Announces Conference Call to Discuss Third Quarter 2008 Results
11. RainDance Technologies Delivers RDT 1000, Sequence Enrichment Solution to The Genome Center at Washington University School of Medicine in St. Louis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)...  Prima Biomed Ltd. (NASDAQ: PBMD ) a ... a leader in the development of immunotherapeutic products for ... CVac data from the Phase II CAN-003 ovarian cancer ... clinically meaningful improvement in Overall Survival ("OS") over standard ... In the group of second remission patients (n=20), the ...
(Date:5/21/2015)... , May 21, 2015 Imagine ... feelings - and those of others. Being able to ... Analyze and read people to anticipate their thoughts and ... deepest emotions and feelings to create unique abstract paintings ... responsive games. Get inside a first-person-shooter as it creates ...
(Date:5/21/2015)...  CytRx Corporation (NASDAQ: CYTR ), a ... today announced positive updated results from its ongoing ... treatment of unresectable glioblastoma multiforme (GBM), a deadly ... is designed to investigate the preliminary efficacy and ... progressed following prior treatment with surgery, radiation and ...
(Date:5/21/2015)... 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (TSX.V: ... company focused on the development of autologous cell ... the International Society for Cellular Therapy (ISCT) on ... currently in a Phase 1/2 clinical trial.  The ... from 5:30 PM to 7:00 PM local time, ...
Breaking Biology Technology:Correction Continues after Big Move - BrokerBank Securities, Inc. 25 Days to Meet ARGUS - The World's First Contactless Emotions Scanner 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3
... Industry trade publication DM Review based in ... Solution Awards competition. , ,The award, a symbol of ... has been given out since 1996. Entries are accepted ... as determined by feedback from DM Review readers. , ...
... Madison, Wis. - During a week in which President ... Supreme Court, it would have been easy to overlook the ... the Wisconsin Supreme Court. If you're a business owner worried ... attention to recent decisions by Wisconsin's highest court as you ...
... --A growth consulting company has honored an MRI vital ... 2005 Customer Value Enhancement Award. , ,The Veris monitor, ... through an OEM agreement with Medrad, was honored in ... was jointly developed by Criticare and Medrad. The product ...
Cached Biology Technology:DM Review announces award finalists 2Business liability law complaints grow with state Supreme Court decisions 2Business liability law complaints grow with state Supreme Court decisions 3
(Date:4/13/2015)... , April 13, 2015 ... Research, "Global Biometrics Market Forecast & Opportunities, 2020", the ... CAGR of around 14% till 2020. The biometrics ... large scale implementation and review of biometric management ... of new products with greater efficiency, are resulting ...
(Date:4/10/2015)... DUBLIN , April 10, 2015 ... the addition of the "Security Competitive Profiles - ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , NEC will continue to ... solutions to the market, with a company focus on ... solution anticipated. Winning opportunities in the ...
(Date:4/8/2015)... , April 8, 2015  Infinisource, a leading ... services, and Morpho, a leading supplier of biometric ... produce the market,s most advanced biometrically-enabled time clock, ... NXG time clock is setting a bold, new ... data for the small and mid-size employer. When ...
Breaking Biology News(10 mins):Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2NEC Security Competitive Profile 2015 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3
... amphibian species at an accelerating rate in recent decades, ... 2003. At the same time, amphibians are, for reasons ... or birds, underscoring the importance of an accurate evaluation. ... of BioScience, the monthly journal of the American Institute ...
... running, reports a team of scientists from The University of ... for the environment. Arizona farmers who plant the biotech cotton ... in the past. , Insect pests sometimes evolve resistance to ... was predicted for biotech crops genetically altered to produce Bt ...
... disease in medieval Europe ?to fade from the scene? ... there. , The reason seems to be, say researchers ... that tuberculosis, a far more deadly disease, overtook leprosy, ... upon the examination of DNA from human remains from ...
Cached Biology News:New amphibian species result from exploration, not from rule changes 2Biotech cotton 8: Bugs 0 2Biotech cotton 8: Bugs 0 3Once-dreaded leprosy 'replaced' by tuberculosis, say researchers 2
TRIS-EDTA based buffer prepared from RNase-free water suitable for storage and dilution of siRNA, pH 8, store at 4 C ...
Request Info...
Request Info...
...
Biology Products: